Skip to main content

Why has Manitoba been so slow to approve the use of new and effective monoclonal antibodies.

 On Thursday November 25th, I asked the Minister of Health why her government has been so slow to approve the use of two monoclonal antibodies (MAbs)which have been shown to the very effective in reducing hospital and ICU needs and reducing deaths from COVID-19.   These monoclonal antibodies have been approved for use and have been used for the last three months in Ontario, and have been similarly approved for use in British Columbia and Alberta.  The use of these monoclonal antibodies have the potential to reduce the need for ICU beds from COVID and to reduce deaths.  Their use could potentially have decreased the need for ICU beds sufficiently that we would not have needed to transport patients hundreds of kilometers away from their homes in order to free up hospital space. My question and the Minister's response is below (from Hansard). 

MAbs for Early COVID Treatment
Approval for Use in Manitoba

Hon. Jon Gerrard (River Heights): Madam Speaker, two monoclonal antibodies, casirivimab and imdevimab–colloquially called mAbs–are remark­ably effective in the early treatment of COVID, decreasing the number of people having to go to the ICU or dying by up to 70 per cent. These mAbs are now widely used in BC, Alberta and Ontario, including in Sioux Lookout and Thunder Bay, but not in Manitoba, because this Province has not acted with the urgency needed.

      Why is the Province hesitating to approve these mAbs when they save lives and decrease ICU use and can enable Manitoba to return to elective surgeries and address the enormous backlog which we have now?

Hon. Audrey Gordon (Minister of Health and Seniors Care): I thank the member for–from River Heights for the question.

      Our gov­ern­ment continues to seek the advice and listen to the experts at Public Health, as well as the national advisory council on immunization. The best defence we have against COVID‑19 is for individuals to get vaccinated. When new drugs become available, once again, we seek the advice of public health experts.

      As you know, Madam Speaker, earlier this year, I also changed regula­tion to make it easier for us to add new drugs to the formulary, and I look forward to hearing more from Public Health as new drugs come to the market.

In addition to the question above, I commented on two other occasions on the failure of the government to quickly approve the use of the mAbs in Manitoba.  These comments are below: 

From my Comments on the Throne Speech – Thursday November 25th

The COVID pandemic continues and now is in the middle of the fourth wave. The projections from our chief public health officer, Dr. Brent Roussin, are that it will get worse.

      Already, many surgical and diag­nos­tic pro­cedures are being postponed. Postponed is a gov­ern­ment euphemism for cancelled, to be rescheduled at some unknown future date. It means the backlog of surgeries and diag­nos­tic tests will grow.

      It did not have to be this way. I have, for example, already written re­peat­edly to the Minister of Health to allow the use of two monoclonal antibodies, mAbs. These two are, spe­cific­ally, casirivimab, and imdevimab, and their use early in the course of COVID‑19 infection has been shown to reduce deaths and to reduce the number of individuals who need ICU care by up to 70 per cent.

      The reduction in the need for ICU care would be sufficient that surgeries would not have needed to be cancelled in the way they were. It's really unfor­tunate that Manitoba has been so slow to approve the use of mAbs. Currently, these mAbs are being used widely in Ontario, in Alberta and BC. Indeed, it's shocking that these mAbs can be used in Sioux Lookout and Thunder Bay, but can't be used in Winnipeg.

      Bob Dylan had a song, when will they ever learn. One wonders whether the current gov­ern­ment will ever learn.


From my Comments on a resolution calling from a Public Inquiry into the conduct of the Pandemic on Thursday December 2.

 In June 2021, Health Canada approved the use of two monoclonal antibodies, colloquially called mAbs, with the specific names casirivimab and imdevimab. These have been shown in rigorous scientific work to be very effective when given early in the course of a COVID infection in a person who is not vaccinated. They reduced the need for hospitalization and for ICU care. The results are very impressive with as much as a 70 per cent reduction in some cases.

      I wrote on October 11 and again on October 22nd to the Minister of Health to urge her to approve the use of these mAbs and then asked in QP last week. Ontario, BC and Alberta have already been using them for some time, including in Sioux Lookout in rural Ontario. But in Winnipeg, a hub of expertise in infectious diseases, we still can't use them. Ouch. I dread to consider how many people in Manitoba have died when they could have been saved if these agents had been approved here much more quickly, as they were in Ontario.

      Just because some in Manitoba have not got vaccinated doesn't mean they shouldn't be helped. These people may be misinformed but they are not bad people. They should be helped. They should not die when we can prevent it


Popular posts from this blog

Dougald Lamont speaks at Meth Forum last night to present positive ideas to address the epidemic, while exposing the lack of action by the Pallister Conservatives

Last night at the Notre Dame Recreation Centre in St. Boniface, at an Election Forum on the Meth Crisis in Manitoba, Dougald Lamont spoke eloquently about the severity of the meth epidemic and described the Liberal plan to address it.  The Liberal Plan will make sure that there is a single province-wide phone number for people, or friends of people, who need help dealing with meth to call (as there is in Alberta) and that there will be rapid access to a seamless series of steps - stabilization, detoxification, treatment, extended supportive housing etc so that people with meth addiction can be helped well and effectively and so that they can rebuild their lives.  The Liberal meth plan will be helped by our approach to mental health (putting psychological therapies under medicare), and to poverty (providing better support).  It will also be helped by our vigorous efforts to help young people understand the problems with meth in our education system and to provide alternative positive

Manitoba Liberal accomplishments

  Examples of Manitoba Liberal accomplishments in the last three years Ensured that 2,000 Manitoba fishers were able to earn a living in 2020   (To see the full story click on this link ). Introduced a bill that includes retired teachers on the Pension Investment Board which governs their pension investments. Introduced amendments to ensure school aged children are included in childcare and early childhood education plans moving forward. Called for improvements in the management of the COVID pandemic: ·          We called for attention to personal care homes even before there was a single case in a personal care home. ·            We called for a rapid response team to address outbreaks in personal care homes months before the PCs acted.  ·          We called for a science-based approach to preparing schools to   improve ventilation and humidity long before the PCs acted. Helped hundreds of individuals with issues during the pandemic including those on social assistance

The Indigenous Science Conference in Winnipeg June 14-16

  June 14 to 16, I spent three days at the Turtle Island Indigenous Science Conference.  It was very worthwhile.   Speaker after speaker talked of the benefits of using both western or mainstream science and Indigenous science.  There is much we can learn from both approaches.   With me above is Myrle Ballard, one of the principal organizers of the conference.  Myrle Ballard, from Lake St. Martin in Manitoba, worked closely with Roger Dube a professor emeritus at Rochester Institute of Technology, and many others to make this conference, the first of its kind, a success.  As Roger Dube, Mohawk and Abenaki, a physicist, commented "My feeling is that the fusion of traditional ecological knowledge and Western science methodology should rapidly lead the researchers to much more holistic solutions to problems."   Dr. Myrle Ballard was the first person from her community to get a PhD.  She is currently a professor at the University of Manitoba and the Director of Indigenous Science